Selenoprotein P (SeP) is a widely present extracellular glycoprotein [67,68], and its levels are found to be increased in individuals with conditions, such as NAFLD, T2D, and visceral obesity [69,70]. Here, SELENOP is linked to metabolic dysfunction-associated steatotic liver disease.